Nerve side effects study for new bladder cancer treatment
Part of Brain & nervous system, Cancer clinical trials.
This study watches for nerve problems in people getting enfortumab vedotin and pembrolizumab as their first treatment for advanced bladder cancer. It aims to understand how common these side effects are and how they affect patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have advanced bladder cancer that has spread or cannot be removed by surgery
- You have not had any other treatment for your advanced bladder cancer
- You are able to receive the study drugs enfortumab vedotin and pembrolizumab
- You have not taken certain chemotherapy or immunotherapy in the last 12 months before surgery
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at nerve problems (peripheral neuropathy) in people with muscle-invasive bladder cancer who receive a combination of two drugs, enfortumab vedotin and pembrolizumab, before or after surgery. The goal is to understand how these treatments affect nerves and to help manage side effects.
This trial tests a new drug, PF-08634404, either by itself or together with another drug called enfortumab vedotin, for people with advanced bladder cancer that has spread. The goal is to see if these treatments can shrink tumors or slow the cancer's growth.
This study looks at how enfortumab vedotin, a cancer drug, affects the nerves. It aims to understand and track neuropathy (nerve damage) in people with urothelial carcinoma, so doctors can better manage side effects.
This study looks at a new treatment for advanced bladder cancer (urothelial carcinoma) using two drugs, enfortumab vedotin and pembrolizumab, which help the immune system fight cancer. The study also tests a supportive therapy called Neuridase to help prevent or reduce nerve damage (peripheral neuropathy) that can be a side effect of the cancer treatment.
This trial looks at how a new treatment for advanced bladder cancer, called enfortumab vedotin, might affect your nerves. It aims to understand any nerve-related side effects so doctors can better manage them.
This study tests a new drug called enfortumab vedotin for people whose advanced urothelial cancer (bladder or urinary tract cancer) has not responded to prior immunotherapy (checkpoint inhibitors) and platinum chemotherapy. The goal is to see how safe and effective this treatment is for Indian adults.
Hear when a new Urothelial Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.